S. Stilo

发表

The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study

E. Vassos, C. Iyegbe, F. Gaughran, 2020, Schizophrenia Research.

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

Peter B. Jones, R. Murray, M. Ruggeri, 2019, The lancet. Psychiatry.

Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use.

Peter B. Jones, R. Murray, M. Ruggeri, 2019, Schizophrenia bulletin.

Different types of childhood adversity and 5-year outcomes in a longitudinal cohort of first-episode psychosis patients

M. D. Forti, R. Murray, C. Pariante, 2018, Psychiatry Research.

The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme

Peter B. Jones, R. Murray, M. Ruggeri, 2020, Social Psychiatry and Psychiatric Epidemiology.

Non-Genetic Factors in Schizophrenia

R. Murray, S. Stilo, R. Murray, 2019, Current Psychiatry Reports.

First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data

E. Vassos, S. Tosato, P. Sham, 2022, Schizophrenia bulletin.

Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis

R. Murray, G. Sugranyes, M. Picchioni, 2011, Schizophrenia Research.

Migration history and risk of psychosis: results from the multinational EU-GEI study

Peter B. Jones, R. Murray, S. Tosato, 2021, Psychological Medicine.

Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study

Peter B. Jones, S. Tosato, J. Bobes, 2022, Psychological Medicine.

PAGES_DCNS 46_5.qxd:DCNS#45

R. Murray, S. Stilo, R. Murray, 2010 .

Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.

R. Murray, A. David, C. Pariante, 2014, Schizophrenia bulletin.

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations.

D. Rujescu, R. Murray, M. Ruggeri, 2014, Schizophrenia bulletin.

Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study

R. Murray, A. David, P. Gardner-Sood, 2018, Psychological Medicine.

Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users

R. Murray, C. Pariante, J. Powell, 2012, Biological Psychiatry.

The Maudsley environmental risk score for psychosis

R. Murray, E. Vassos, P. Sham, 2018, bioRxiv.

The Maudsley environmental risk score for psychosis

R. Murray, E. Vassos, P. Sham, 2018, bioRxiv.

Differences in cannabis-related experiences between patients with a first episode of psychosis and controls

R. Murray, A. David, D. Prata, 2015, Psychological Medicine.

Jumping to conclusions, neuropsychological functioning, and delusional beliefs in first episode psychosis.

R. Murray, A. David, D. Freeman, 2015, Schizophrenia bulletin.

High-potency cannabis and the risk of psychosis

Alessandra Paparelli, Rowena Handley, Paola Dazzan, 2009, British Journal of Psychiatry.

The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study

Peter B. Jones, M. Ruggeri, E. Vassos, 2021, Translational Psychiatry.

Environmental risk factors for schizophrenia: implications for prevention

R. Murray, S. Stilo, M. Forti, 2011 .

Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosis

R. Murray, C. Pariante, D. Stamate, 2017, Schizophrenia Research.

Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.

Paola Dazzan, Tiago Reis Marques, Michael Lynskey, 2015, The lancet. Psychiatry.

Interaction between cannabis consumption and childhood abuse in psychotic disorders: preliminary findings on the role of different patterns of cannabis use

R. Murray, C. La Cascia, D. la Barbera, 2015, Early intervention in psychiatry.

Impact of childhood adversities on specific symptom dimensions in first-episode psychosis

R. Murray, E. Vassos, A. David, 2015, Psychological Medicine.

Depression, Anxiety and Anger in Subtypes of Irritable Bowel Syndrome Patients

A. Bruno, P. Consolo, G. Giacobbe, 2010, Journal of Clinical Psychology in Medical Settings.

Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study

S. Tosato, P. Sham, J. Bobes, 2023, Molecular Psychiatry.

Tobacco use in first-episode psychosis, a multinational EU-GEI study.

J. Sanjuán, J. van Os, M. Arrojo, 2023, Psychological medicine.

Social Disadvantage: Cause or Consequence of Impending Psychosis?

R. Murray, A. David, C. Pariante, 2010, Schizophrenia Research.

Cannabis users have higher premorbid IQ than other patients with first onset psychosis

R. Murray, A. Reichenberg, P. Gardner-Sood, 2013, Schizophrenia Research.

Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study

Peter B. Jones, R. Murray, E. Vassos, 2022, Psychological Medicine.

Role of Environmental Confounding in the Association between FKBP5 and First-Episode Psychosis

R. Murray, A. David, C. Pariante, 2014, Front. Psychiatry.

Further evidence of a cumulative effect of social disadvantage on risk of psychosis

R. Murray, C. Pariante, V. Mondelli, 2016, Psychological Medicine.

The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study

M. Ruggeri, S. Tosato, M. Leboyer, 2023, Social Psychiatry and Psychiatric Epidemiology.

The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study.

E. Vassos, S. Tosato, P. Sham, 2023, Psychological medicine.

Use of multiple Polygenic Risk Scores for distinguishing Schizophrenia-spectrum disorder and Affective psychosis categories; the EUGEI study

Peter B. Jones, E. Vassos, S. Tosato, 2021, medRxiv.

Failure to find association between childhood abuse and cognition in first-episode psychosis patients

D. la Barbera, H. Fisher, M. di Forti, 2014, European Psychiatry.

Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.

A. David, C. Pariante, J. Powell, 2015, The lancet. Psychiatry.

Impact of childhood adversities on specific symptom dimensions in first-episode psychosis

E. Vassos, C. Pariante, F. Gaughran, 2015, Psychological Medicine.

Jumping to conclusions, neuropsychological functioning, and delusional beliefs in first episode psychosis.

A. David, D. Freeman, S. Jolley, 2015, Schizophrenia bulletin.

Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study

S. Tosato, J. Sanjuán, D. Berardi, 2022 .

PAGES_DCNS 46_5.qxd:DCNS#45

S. Stilo, R. Murray, 2010 .

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations.

D. Rujescu, M. Ruggeri, S. Tosato, 2014, Schizophrenia bulletin.

Self-reported suicidal ideation among individuals with first episode psychosis and healthy controls: Findings from the international multicentre EU-GEI study

S. Tosato, B. Pignon, C. Bonetto, 2024, Schizophrenia Research.

Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study.

E. Vassos, S. Tosato, A. Richards, 2024, Psychological medicine.